Warren Buffett has a record-high cash pile of $277bn. Should I stop investing?

Oliver Rodzianko, a Warren Buffett devotee, is assessing his own investing strategy as the legendary investor holds more cash than usual.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Warren Buffett would know if the US stock market was overvalued and due for a correction or crash. The fact that the Oracle of Omaha has been building his cash position, now at a record $277bn, could indicate that the valuation of many top American companies is currently unsustainable.

However, Buffett has also been securing Berkshire Hathaway’s legacy, including passing on the reins to new CEO-in-waiting Greg Abel. So, I think the big cash pile could be the investor’s way of allowing for flexibility and readiness for Abel’s tenure while preserving his remarkable track record.

Should I stop investing?

Firstly, I will never stop investing. I believe that there are always companies that the market is undervaluing and are worth my money, even in the hardest of times.

Should you invest £1,000 in Smith & Nephew Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Smith & Nephew Plc made the list?

See the 6 stocks

However, I also think that the valuation of the S&P 500, which is America’s most famous index, is potentially problematically high right now.

A lot of the recent growth has been in big tech firms. These include Nvidia, Alphabet, and Amazon‘s AI developments. The broader base of the 500 companies, on the other hand, has seen slower growth.


Created at TradingView

Nvidia alone has accounted for over a third of the S&P 500’s gains in 2024. Furthermore, analysts have noted that while the S&P 500 is projected to show 10% year-on-year earnings growth, this drops to just 6% when excluding the ‘Magnificent Seven’.

AI growth looks like it is going to slow down somewhat after a really bullish couple of years. So, I think the index could be in for a short-term correction.

Where should I look instead?

At the moment, I’m particularly fond of companies that have diversified well internationally. The Western markets are currently quite vulnerable to high inflation and contractions in GDP growth. However, India is now the highest growth nation in the world.

Thankfully, there are certain US-listed companies that operate in India. For example, Dr Reddy’s Laboratories (NYSE:RDY) has 17.5% of its revenue from India, 8% from Russia, and 26% from other countries. While the US is 48.5% of its total revenue base, the company still provides the good level of geographic diversification that I’m after.

Also, Dr Reddy’s has a decent valuation. Its price-to-earnings (P/E) ratio is 21, which is much lower than its 10-year median of 27. Furthermore, it has a robust three-year annual revenue growth of nearly 14% and earnings growth of 33%. So, I definitely consider this worthy of my watchlist.

However, investing in diverse markets comes with risks, especially in pharmaceuticals. A heavy concentration in India and Russia means that if policies and regulations change there, Dr Reddy’s could struggle to compete. It’s normal for global pharma companies to have to navigate diverse regulatory landscapes. However, Dr Reddy’s has concentrated more than Merck or Pfizer on specific non-Western countries, excluding China.

I’m diversifying

I’m looking to get away from some of the valuation risk and growth slowdown concerns in America. Buffett’s cash pile doesn’t mean that I should stop investing entirely. To me, it indicates a time to start assessing the risk in the US markets. After all, that’s where the investor has predominantly made his money. So, for now, I’m putting companies like Dr Reddy’s on my watchlist rather than Nvidia.

Like buying £1 for 31p

This seems ridiculous, but we almost never see shares looking this cheap. Yet this Share Advisor pick has a price/book ratio of 0.31. In plain English, this means that investors effectively get in on a business that holds £1 of assets for every 31p they invest!

Of course, this is the stock market where money is always at risk — these valuations can change and there are no guarantees. But some risks are a LOT more interesting than others, and at The Motley Fool we believe this company is amongst them.

What’s more, it currently boasts a stellar dividend yield of around 10%, and right now it’s possible for investors to jump aboard at near-historic lows. Want to get the name for yourself?

See the full investment case

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Oliver Rodzianko has positions in Alphabet and Amazon. The Motley Fool UK has recommended Alphabet, Amazon, and Nvidia. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

artificial intelligence investing algorithms
Investing Articles

Up 272% in just a year, is Palantir stock just getting started?

This writer recognises that Palantir has grown its business very well -- but does the stock price offer him an…

Read more »

Runner standing at the starting point with 2025 year for starting in new year 2025 to achieve business planing and success concept.
Investing Articles

Up 50%? The Aston Martin share price forecast is mind-blowing! 

If analysts are right, the Aston Aston Martin share price could absolutely rocket in the year ahead. Harvey Jones says…

Read more »

Investing Articles

As the S&P 500 drops, here are 2 Stocks and Shares ISA holdings I’m watching

Our writer has different views on how President Trump's tariffs might affect these two US holdings in his Stocks and…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

£10,000 invested in Tesla stock at Christmas is now worth…

Tesla stock has been one of best-performing investments of the past decade. But things haven't gone to plan for investors…

Read more »

Investing Articles

Up 279% in 5 years, could Meta stock keep soaring?

Meta stock has more than tripled in five years. This writer sees lots to like about the business but also…

Read more »

Pink 3D image of the numbers '2025' growing in size
Investing Articles

25% total return in a year? Is now the perfect time to buy BP shares?

BP shares are on the front line of today's global economic and political uncertainty but analysts think they can still…

Read more »

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

With Cash ISA changes coming, could now be the time to consider buying shares?

Changes to the Cash ISA could lead to greater investment in the stock market. This could be a good thing…

Read more »

Investing Articles

These FTSE 100 dividend shares just got cheaper, thanks to President Trump!

Investors buying dividend shares can lock in bigger long-term yields when share prices take a tumble. These two just did…

Read more »